BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34210413)

  • 1. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
    J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction.
    Schuermans A; Honigberg MC; Raffield LM; Yu B; Roberts MB; Kooperberg C; Desai P; Carson AP; Shah AM; Ballantyne CM; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB; Reiner AP
    JAMA Netw Open; 2024 Jan; 7(1):e2353244. PubMed ID: 38270950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.
    Bhattacharya R; Zekavat SM; Haessler J; Fornage M; Raffield L; Uddin MM; Bick AG; Niroula A; Yu B; Gibson C; Griffin G; Morrison AC; Psaty BM; Longstreth WT; Bis JC; Rich SS; Rotter JI; Tracy RP; Correa A; Seshadri S; Johnson A; Collins JM; Hayden KM; Madsen TE; Ballantyne CM; Jaiswal S; Ebert BL; Kooperberg C; Manson JE; Whitsel EA; ; Natarajan P; Reiner AP
    Stroke; 2022 Mar; 53(3):788-797. PubMed ID: 34743536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Clonal Hematopoiesis of Indeterminate Potential with Incident Heart Failure with Preserved Ejection Fraction.
    Reiner AP; Roberts MB; Honigberg MC; Kooperberg C; Desai P; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB
    medRxiv; 2023 Jun; ():. PubMed ID: 37333361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis of Indeterminate Potential With Loss of
    Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
    Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
    Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
    Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
    Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
    Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
    Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
    JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
    J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
    Cochran JD; Yura Y; Thel MC; Doviak H; Polizio AH; Arai Y; Arai Y; Horitani K; Park E; Chavkin NW; Kour A; Sano S; Mahajan N; Evans M; Huba M; Naya NM; Sun H; Ban YH; Hirschi KK; Toldo S; Abbate A; Druley TE; Ruberg FL; Maurer MS; Ezekowitz JA; Dyck JRB; Walsh K
    Circulation; 2023 Oct; 148(15):1165-1178. PubMed ID: 37681311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
    Ahn HJ; An HY; Ryu G; Lim J; Sun C; Song H; Choi SY; Lee H; Maurer T; Nachun D; Kwon S; Lee SR; Lip GYH; Oh S; Jaiswal S; Koh Y; Choi EK
    Eur Heart J; 2024 Mar; 45(10):778-790. PubMed ID: 38231881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers.
    Shi C; Aboumsallem JP; Suthahar N; de Graaf AO; Jansen JH; van Zeventer IA; Bracun V; de Wit S; Screever EM; van den Berg PF; Meijers WC; Gansevoort RT; Bakker SJL; van der Harst P; Silljé HHW; Huls G; de Boer RA
    Eur J Heart Fail; 2023 Jan; 25(1):4-13. PubMed ID: 36221810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms.
    Martínez-Avilés L; Besses C; Álvarez-Larrán A; Torres E; Serrano S; Bellosillo B
    Ann Hematol; 2012 Apr; 91(4):533-41. PubMed ID: 21904853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
    Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.